These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25933742)

  • 1. Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI.
    Kim B; Byun JH; Kim HJ; Won HJ; Kim SY; Shin YM; Kim PN
    Eur Radiol; 2016 Jan; 26(1):191-8. PubMed ID: 25933742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size.
    Kim B; Byun JH; Lee JH; Park BJ; Kwon HJ; Lee JH; Lee SJ; Won HJ; Shin YM; Kim PN
    Clin Radiol; 2018 Mar; 73(3):244-253. PubMed ID: 29111237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing hemangiomas from metastases on liver MRI performed with gadoxetate disodium: Value of the extended washout sign.
    Agarwal S; Grajo JR; Fuentes-Orrego JM; Abtahi SM; Harisinghani MG; Saini S; Hahn PF
    Eur J Radiol; 2016 Mar; 85(3):635-40. PubMed ID: 26860678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.
    Tamada T; Ito K; Yamamoto A; Sone T; Kanki A; Tanaka F; Higashi H
    AJR Am J Roentgenol; 2011 Apr; 196(4):824-30. PubMed ID: 21427331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
    Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
    Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein.
    Feuerlein S; Boll DT; Gupta RT; Ringe KI; Marin D; Merkle EM
    AJR Am J Roentgenol; 2011 Jan; 196(1):W18-24. PubMed ID: 21178026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?
    Vernuccio F; Cannella R; Gozzo C; Greco V; Midiri M; Furlan A; Tang A; Brancatelli G
    Abdom Radiol (NY); 2020 Aug; 45(8):2409-2417. PubMed ID: 32435849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Shiratori Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors.
    Chernyak V; Kim J; Rozenblit AM; Mazzoriol F; Ricci Z
    J Magn Reson Imaging; 2011 Aug; 34(2):301-9. PubMed ID: 21608069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation.
    Jeong HT; Kim MJ; Chung YE; Choi JY; Park YN; Kim KW
    AJR Am J Roentgenol; 2013 Oct; 201(4):W603-11. PubMed ID: 24059399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Hemangiomas: Factors Associated with Pseudo Washout Sign on Gd-EOB-DTPA-enhanced MR Imaging.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Nakamura F
    Magn Reson Med Sci; 2016; 15(1):73-82. PubMed ID: 26346400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the transitional phase at gadoxetate disodium-enhanced hepatic MRI for the diagnosis of hepatocellular carcinoma: preliminary results.
    Nakamura Y; Toyota N; Date S; Oda S; Namimoto T; Yamashita Y; Beppu T; Awai K
    J Comput Assist Tomogr; 2011; 35(6):723-7. PubMed ID: 22082543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?
    Joo I; Lee JM; Lee DH; Jeon JH; Han JK; Choi BI
    Eur Radiol; 2015 Oct; 25(10):2859-68. PubMed ID: 25773941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
    Allen BC; Ho LM; Jaffe TA; Miller CM; Mazurowski MA; Bashir MR
    AJR Am J Roentgenol; 2018 Jun; 210(6):1266-1272. PubMed ID: 29629800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadoxetate disodium-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: late portal venous phase may improve identification of enhancing capsule.
    Kim H; Kim SS; Shin HC; Choi SY; Lee JE; Lee WH; Park CH; Lee HN; Kim SY; Park H; Heo NH
    Abdom Radiol (NY); 2023 Feb; 48(2):621-629. PubMed ID: 36494608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of qualitative and quantitative imaging features of hepatic hemangiomas with and without pseudo-washout sign on gadoxetic acid-enhanced MRI: a descriptive and comparative study.
    Aslan S; Onder RO; Sulun E; Taşdemir MN
    Acta Radiol; 2024 Jan; 65(1):23-32. PubMed ID: 37264586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.
    Kim SY; Wu EH; Park SH; Wang ZJ; Hope TA; Yee J; Zhao LQ; Chang WC; Yeh BM
    Abdom Radiol (NY); 2016 Aug; 41(8):1522-31. PubMed ID: 26971341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.